Brooklands Fund Management Ltd acquired a new stake in shares of Ovintiv Inc. (NYSE:OVV - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 56,000 shares of the company's stock, valued at approximately $3,238,000.
Other hedge funds have also recently modified their holdings of the company. TOWER TRUST & INVESTMENT Co raised its position in Ovintiv by 1.0% during the 3rd quarter. TOWER TRUST & INVESTMENT Co now owns 14,833 shares of the company's stock worth $857,000 after buying an additional 142 shares during the last quarter. Integrated Wealth Concepts LLC boosted its holdings in shares of Ovintiv by 5.0% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 5,460 shares of the company's stock valued at $287,000 after acquiring an additional 260 shares during the last quarter. CX Institutional boosted its holdings in shares of Ovintiv by 1.0% in the 2nd quarter. CX Institutional now owns 28,363 shares of the company's stock valued at $1,493,000 after acquiring an additional 276 shares during the last quarter. Root Financial Partners LLC boosted its holdings in shares of Ovintiv by 43.2% in the 1st quarter. Root Financial Partners LLC now owns 918 shares of the company's stock valued at $54,000 after acquiring an additional 277 shares during the last quarter. Finally, Sanctuary Advisors LLC increased its stake in shares of Ovintiv by 2.6% in the first quarter. Sanctuary Advisors LLC now owns 13,020 shares of the company's stock worth $773,000 after acquiring an additional 324 shares during the period. Institutional investors and hedge funds own 83.81% of the company's stock.
Insider Activity at Ovintiv
In related news, EVP Rachel Moore sold 7,753 shares of the business's stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $63.32, for a total transaction of $490,919.96. Following the completion of the sale, the executive vice president directly owned 72,530 shares in the company, valued at approximately $4,592,599.60. The trade was a 9.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.85% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the stock. UBS Group restated a "buy" rating and set a $85.00 target price on shares of Ovintiv in a research report on Monday, September 14th. Scotiabank lifted their price objective on Ovintiv from $75.00 to $80.00 and gave the company a "sector outperform" rating in a research note on Monday, October 19th. Truist Financial lifted their price objective on Ovintiv from $73.00 to $77.00 and gave the company a "buy" rating in a research note on Monday, October 12th. Seaport Research Partners began coverage on Ovintiv in a report on Thursday, September 3rd. They issued a "neutral" rating for the company. Finally, Stifel Nicolaus initiated coverage on Ovintiv in a research note on Wednesday, September 9th. They issued a "buy" rating and a $92.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $72.32.
Get Our Latest Stock Analysis on OVV
Ovintiv News Roundup
Here are the key news stories impacting Ovintiv this week:
- Positive Sentiment: Zacks upgraded Ovintiv to Rank #1, “Strong Buy,” from “Hold,” citing improving earnings prospects. The upgrade could attract additional momentum-oriented buying. Ovintiv Upgraded to Strong Buy
- Positive Sentiment: National Bank Financial raised its price target to $95 from $94 and maintained an “outperform” rating. The revised target implied approximately 33% upside from the referenced share price, signaling continued analyst confidence. National Bank Financial Recommendations
- Positive Sentiment: Stifel Nicolaus reaffirmed its Buy rating, reinforcing the broader Wall Street consensus around Ovintiv’s outlook. Stifel Reaffirms Buy Rating
- Positive Sentiment: An analysis of Ovintiv’s Logan acquisition argued that the deal strengthens the company’s liquids-growth profile and supported a “Strong Buy” view. Successful integration and liquids expansion could improve future cash flow. Logan Acquisition Enhances Liquids Growth
- Neutral Sentiment: Ovintiv was also included in several Zacks “Strong Buy” lists focused on momentum, value and income stocks. These rankings improve visibility but largely repeat the broader Zacks upgrade rather than introduce new company-specific developments.
Ovintiv Stock Up 0.3%
OVV opened at $71.52 on Friday. Ovintiv Inc. has a twelve month low of $35.47 and a twelve month high of $73.61. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $64.87 and a 200 day moving average price of $57.25. The company has a market cap of $19.70 billion, a PE ratio of 11.58 and a beta of 0.65.
About Ovintiv
(
Free Report)
Ovintiv Inc is an independent energy company engaged in the exploration, development, production and marketing of oil, condensate, natural gas liquids and natural gas. The company's operations are focused on North America, with production and resource development activities in the United States and Canada.
Ovintiv's U.S. operations include assets in the Permian Basin of Texas and New Mexico and the Uinta Basin of Utah. In Canada, the company's portfolio includes the Montney and Horn River natural gas and liquids-rich plays in British Columbia and Alberta.
Read More
Want to see what other hedge funds are holding OVV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ovintiv Inc. (NYSE:OVV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ovintiv, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.
While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.